Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine if intravenous administration of the metal ion
trapping agent DP-b99 up to 9 hours following acute ischemic stroke onset, and then for 3
additional days (4 consecutive days in total) is effective in improving long term outcome.
Patients will be followed up for 3 months after the stroke.